vs
Leslie's, Inc.（LESL）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Leslie's, Inc.的季度营收约是再鼎医药的1.2倍（$147.1M vs $127.1M），再鼎医药同比增速更快（17.1% vs -16.0%），再鼎医药自由现金流更多（$-26.7M vs $-85.5M），过去两年再鼎医药的营收复合增速更高（20.8% vs -11.7%）
莱斯利公司（Leslie's, Inc.）主营游泳池相关用品零售，旗下运营莱斯利游泳池用品品牌，是全球规模最大的游泳池用品零售商。公司总部坐落于美国亚利桑那州凤凰城，在亚利桑那、加利福尼亚、佛罗里达、佐治亚及得克萨斯等州拥有极强的零售布局优势。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
LESL vs ZLAB — 直观对比
营收规模更大
LESL
是对方的1.2倍
$127.1M
营收增速更快
ZLAB
高出33.2%
-16.0%
自由现金流更多
ZLAB
多$58.8M
$-85.5M
两年增速更快
ZLAB
近两年复合增速
-11.7%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $147.1M | $127.1M |
| 净利润 | $-83.0M | — |
| 毛利率 | 18.4% | 51.0% |
| 营业利润率 | -46.7% | -54.6% |
| 净利率 | -56.4% | — |
| 营收同比 | -16.0% | 17.1% |
| 净利润同比 | -86.2% | — |
| 每股收益（稀释后） | $-8.92 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LESLZLAB
| Q1 26 | $147.1M | — | ||
| Q4 25 | $389.2M | $127.1M | ||
| Q3 25 | — | $115.4M | ||
| Q2 25 | $500.3M | $109.1M | ||
| Q1 25 | $177.1M | $105.7M | ||
| Q4 24 | $175.2M | $108.5M | ||
| Q3 24 | $397.9M | $101.8M | ||
| Q2 24 | $569.6M | $100.1M |
净利润LESLZLAB
| Q1 26 | $-83.0M | — | ||
| Q4 25 | $-162.8M | — | ||
| Q3 25 | — | $-36.0M | ||
| Q2 25 | $21.7M | $-40.7M | ||
| Q1 25 | $-51.3M | $-48.4M | ||
| Q4 24 | $-44.6M | — | ||
| Q3 24 | $-9.9M | $-41.7M | ||
| Q2 24 | $60.6M | $-80.3M |
毛利率LESLZLAB
| Q1 26 | 18.4% | — | ||
| Q4 25 | 38.6% | 51.0% | ||
| Q3 25 | — | 59.5% | ||
| Q2 25 | 39.6% | 60.6% | ||
| Q1 25 | 24.8% | 63.6% | ||
| Q4 24 | 27.2% | 61.5% | ||
| Q3 24 | 36.0% | 64.1% | ||
| Q2 24 | 40.2% | 64.9% |
营业利润率LESLZLAB
| Q1 26 | -46.7% | — | ||
| Q4 25 | -38.6% | -54.6% | ||
| Q3 25 | — | -42.3% | ||
| Q2 25 | 13.7% | -50.3% | ||
| Q1 25 | -27.3% | -53.3% | ||
| Q4 24 | -22.7% | -62.6% | ||
| Q3 24 | 6.6% | -66.6% | ||
| Q2 24 | 17.2% | -76.0% |
净利率LESLZLAB
| Q1 26 | -56.4% | — | ||
| Q4 25 | -41.8% | — | ||
| Q3 25 | — | -31.2% | ||
| Q2 25 | 4.3% | -37.3% | ||
| Q1 25 | -29.0% | -45.8% | ||
| Q4 24 | -25.4% | — | ||
| Q3 24 | -2.5% | -40.9% | ||
| Q2 24 | 10.6% | -80.2% |
每股收益（稀释后）LESLZLAB
| Q1 26 | $-8.92 | — | ||
| Q4 25 | $-20.59 | $-0.05 | ||
| Q3 25 | — | $-0.03 | ||
| Q2 25 | $0.12 | $-0.04 | ||
| Q1 25 | $-0.28 | $-0.04 | ||
| Q4 24 | $-4.82 | $-0.09 | ||
| Q3 24 | $-2.46 | $-0.04 | ||
| Q2 24 | $0.33 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.6M | $689.6M |
| 总债务越低越好 | $781.6M | — |
| 股东权益账面价值 | $-489.9M | $715.5M |
| 总资产 | $649.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LESLZLAB
| Q1 26 | $3.6M | — | ||
| Q4 25 | $64.3M | $689.6M | ||
| Q3 25 | — | $717.2M | ||
| Q2 25 | $42.7M | $732.2M | ||
| Q1 25 | $17.3M | $757.3M | ||
| Q4 24 | $11.6M | $779.7M | ||
| Q3 24 | $108.5M | $616.1M | ||
| Q2 24 | $74.4M | $630.0M |
总债务LESLZLAB
| Q1 26 | $781.6M | — | ||
| Q4 25 | $756.6M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $776.6M | — | ||
| Q1 25 | $858.1M | — | ||
| Q4 24 | $796.6M | — | ||
| Q3 24 | $783.7M | — | ||
| Q2 24 | $783.7M | — |
股东权益LESLZLAB
| Q1 26 | $-489.9M | — | ||
| Q4 25 | $-408.0M | $715.5M | ||
| Q3 25 | — | $759.9M | ||
| Q2 25 | $-246.2M | $791.7M | ||
| Q1 25 | $-269.5M | $810.8M | ||
| Q4 24 | $-220.0M | $840.9M | ||
| Q3 24 | $-177.1M | $667.7M | ||
| Q2 24 | $-168.2M | $704.2M |
总资产LESLZLAB
| Q1 26 | $649.4M | — | ||
| Q4 25 | $741.5M | $1.2B | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | $989.5M | $1.2B | ||
| Q1 25 | $1.0B | $1.2B | ||
| Q4 24 | $967.0M | $1.2B | ||
| Q3 24 | $1.1B | $985.3M | ||
| Q2 24 | $1.1B | $987.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-81.1M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-85.5M | $-26.7M |
| 自由现金流率自由现金流/营收 | -58.1% | -21.0% |
| 资本支出强度资本支出/营收 | 2.9% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $7.6M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流LESLZLAB
| Q1 26 | $-81.1M | — | ||
| Q4 25 | $48.2M | $-26.0M | ||
| Q3 25 | — | $-32.0M | ||
| Q2 25 | $114.9M | $-31.0M | ||
| Q1 25 | $-49.2M | $-61.7M | ||
| Q4 24 | $-105.1M | $-55.8M | ||
| Q3 24 | $47.1M | $-26.8M | ||
| Q2 24 | $175.5M | $-42.2M |
自由现金流LESLZLAB
| Q1 26 | $-85.5M | — | ||
| Q4 25 | $41.8M | $-26.7M | ||
| Q3 25 | — | $-35.0M | ||
| Q2 25 | $107.1M | $-33.9M | ||
| Q1 25 | $-55.8M | $-63.2M | ||
| Q4 24 | $-109.8M | $-58.4M | ||
| Q3 24 | $34.1M | $-28.2M | ||
| Q2 24 | $165.2M | $-42.9M |
自由现金流率LESLZLAB
| Q1 26 | -58.1% | — | ||
| Q4 25 | 10.7% | -21.0% | ||
| Q3 25 | — | -30.4% | ||
| Q2 25 | 21.4% | -31.1% | ||
| Q1 25 | -31.5% | -59.9% | ||
| Q4 24 | -62.6% | -53.8% | ||
| Q3 24 | 8.6% | -27.7% | ||
| Q2 24 | 29.0% | -42.9% |
资本支出强度LESLZLAB
| Q1 26 | 2.9% | — | ||
| Q4 25 | 1.7% | 0.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | 1.6% | 2.6% | ||
| Q1 25 | 3.7% | 1.5% | ||
| Q4 24 | 2.7% | 2.4% | ||
| Q3 24 | 3.2% | 1.3% | ||
| Q2 24 | 1.8% | 0.7% |
现金转化率LESLZLAB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 5.29× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.89× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LESL
暂无分部数据
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
